Aperio Group LLC boosted its stake in Israel Chemicals Ltd (NYSE:ICL) by 24.9% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 423,051 shares of the basic materials company’s stock after purchasing an additional 84,347 shares during the period. Aperio Group LLC’s holdings in Israel Chemicals were worth $2,551,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in the business. Swiss National Bank raised its position in Israel Chemicals by 2.7% in the second quarter. Swiss National Bank now owns 2,652,169 shares of the basic materials company’s stock worth $12,117,000 after acquiring an additional 70,216 shares during the period. Van ECK Associates Corp raised its position in shares of Israel Chemicals by 40.4% in the second quarter. Van ECK Associates Corp now owns 2,014,048 shares of the basic materials company’s stock valued at $9,265,000 after purchasing an additional 579,976 shares during the period. Renaissance Technologies LLC raised its position in shares of Israel Chemicals by 10.7% in the second quarter. Renaissance Technologies LLC now owns 757,600 shares of the basic materials company’s stock valued at $3,485,000 after purchasing an additional 73,300 shares during the period. Schroder Investment Management Group raised its position in shares of Israel Chemicals by 43.8% in the second quarter. Schroder Investment Management Group now owns 655,043 shares of the basic materials company’s stock valued at $10,939,000 after purchasing an additional 199,511 shares during the period. Finally, Clal Insurance Enterprises Holdings Ltd raised its position in shares of Israel Chemicals by 2,050.6% in the second quarter. Clal Insurance Enterprises Holdings Ltd now owns 649,982 shares of the basic materials company’s stock valued at $2,990,000 after purchasing an additional 619,759 shares during the period. 8.10% of the stock is currently owned by institutional investors and hedge funds.
Israel Chemicals stock opened at $6.17 on Wednesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.73 and a current ratio of 1.34. The company has a market cap of $7.79 billion, a P/E ratio of 19.90, a PEG ratio of 1.82 and a beta of 1.07. Israel Chemicals Ltd has a 1-year low of $3.85 and a 1-year high of $6.90.
Israel Chemicals (NYSE:ICL) last posted its earnings results on Thursday, November 1st. The basic materials company reported $0.10 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.09 by $0.01. The business had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.38 billion. Israel Chemicals had a net margin of 23.84% and a return on equity of 13.67%. Israel Chemicals’s revenue was down 4.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.09 EPS. Research analysts expect that Israel Chemicals Ltd will post 0.34 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 19th. Investors of record on Tuesday, December 4th will be issued a dividend of $0.051 per share. This represents a $0.20 dividend on an annualized basis and a yield of 3.31%. The ex-dividend date of this dividend is Monday, December 3rd. This is a positive change from Israel Chemicals’s previous quarterly dividend of $0.04. Israel Chemicals’s dividend payout ratio is 32.26%.
Several analysts have recently issued reports on ICL shares. Zacks Investment Research raised shares of Israel Chemicals from a “hold” rating to a “buy” rating and set a $5.25 price target on the stock in a research report on Wednesday, July 11th. ValuEngine raised shares of Israel Chemicals from a “hold” rating to a “buy” rating in a research report on Friday, August 24th. BMO Capital Markets reissued a “hold” rating and issued a $5.25 price target on shares of Israel Chemicals in a research report on Wednesday, September 19th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $6.57 price target on shares of Israel Chemicals in a research report on Sunday, October 21st. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Israel Chemicals has an average rating of “Hold” and a consensus price target of $5.69.
WARNING: This piece of content was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/11/07/aperio-group-llc-increases-holdings-in-israel-chemicals-ltd-icl.html.
Israel Chemicals Profile
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.
Recommended Story: S&P 500 Index
Want to see what other hedge funds are holding ICL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Israel Chemicals Ltd (NYSE:ICL).
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.